Suspension of ulipristal acetate for uterine fibroids during ongoing EMA review of liver injury risk

View source ↗

Summary

EMA suspended Ulipristal acetate for uterine fibroids while reviewing risk of severe liver injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Ulipristal acetate (ulipristal acetate)